Mobia Medical Inc (MOBI) Stock Price, Quote & News

Company Profile

Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The pa...

Industry: Medical Devices

Sector: Healthcare

Phone: (855) 628-9375

Website: www.mobia.com

Address:

2802 Flintrock Trace, Suite 226, Austin, United States

Yingtrader7 Sep. 15 at 4:46 PM

$NSYS volume starting to inflate buy need more uptics. $MOBI moving also

0 · Reply

bigdaddysmang Sep. 11 at 7:47 PM

$MOBI some crazy movement today 🤷‍♂️

0 · Reply

Yingtrader7 Sep. 3 at 4:14 PM

$NSYS somebody please buy out this company. $MOBI

0 · Reply

Yingtrader7 Sep. 2 at 2:45 PM

$NSYS guess who's moving? $MOBI

0 · Reply

OkieDokieTrader Sep. 1 at 6:45 PM

$MOBI $CAST $FRVO $SUJA All IPO's from earlier this year. Starting to run!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

1 · Reply

Yingtrader7 Sep. 1 at 4:46 PM

$MOBI the Alligator Awakens,

0 · Reply

Yingtrader7 Sep. 1 at 4:05 PM

$NSYS top movers $SDGR , $APP , $WING , $MOBI for me.

0 · Reply

Yingtrader7 Sep. 1 at 3:58 PM

$NSYS did you guys forget about $MOBI i hope not

0 · Reply

Yingtrader7 Sep. 1 at 3:57 PM

$MOBI yes yes yes

0 · Reply

Yingtrader7 Aug. 30 at 12:15 PM

$NSYS I think Im going to track $MOBI for next week

0 · Reply

Mobia Medical announces addition of paired VNS to updated AHA stroke guidelines

Aug 28, 2026, 7:30 AM EDT - 18 days ago

Mobia Medical Announces Addition of Paired VNS to Updated AHA Stroke Guidelines

2026-08-17T09:51:22.000Z - 4 weeks ago

Mobia Medical price target raised to $17 from $15 at JPMorgan

Aug 13, 2026, 7:00 AM EDT - 4 weeks ago

Mobia Medical Slides: Investor presentation

Aug 11, 2026, 4:30 PM EDT - 5 weeks ago

Mobia Medical Earnings Call Transcript: Q2 2026

Aug 11, 2026, 4:30 PM EDT - 5 weeks ago

Mobia Medical Earnings release: Q2 2026

Aug 11, 2026, 4:30 PM EDT - 5 weeks ago

Mobia Medical Quarterly report: Q2 2026

Aug 11, 2026, 4:05 PM EDT - 5 weeks ago

Mobia Medical Reports Second Quarter 2026 Financial Results

Aug 3, 2026, 4:05 PM EDT - 6 weeks ago

Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directors

Jul 21, 2026, 4:05 PM EDT - 1 month ago

Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026

Jul 15, 2026, 4:05 PM EDT - 2 months ago

Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors

2026-07-14T20:25:11.000Z - 2 months ago

Mobia Medical publishes two-year follow-up data from VNS-REHAB study

Jul 14, 2026, 4:18 PM EDT - 2 months ago

Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy

Jul 2, 2026, 4:35 PM EDT - 2 months ago

Mobia Medical Announces Vivistim® Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule

2026-06-15T13:41:21.000Z - 3 months ago

Mobia Medical Inc trading resumes

2026-06-15T13:36:20.000Z - 3 months ago

Mobia Medical Inc trading halted, volatility trading pause

Jun 4, 2026, 8:00 AM EDT - 3 months ago

Mobia Medical Quarterly report: Q1 2026

Jun 4, 2026, 7:00 AM EDT - 3 months ago

Mobia Medical Slides: Corporate presentation

2026-06-02T10:26:03.000Z - 3 months ago

Mobia Medical initiated with a Buy at BofA with ‘long growth runway’

2026-06-02T10:24:17.000Z - 3 months ago

Mobia Medical initiated with a Buy at BTIG

2026-06-02T10:16:50.000Z - 3 months ago

Mobia Medical initiated with a Buy at BofA

2026-06-02T09:15:01.000Z - 3 months ago

Mobia Medical initiated with an Overweight at JPMorgan

2026-06-02T08:21:25.000Z - 3 months ago

Mobia Medical initiated with a Buy at Goldman Sachs

2026-05-08T20:59:03.000Z - 4 months ago

Mobia Medical indicated to open at $19.50, IPO priced at $15

2026-05-08T20:16:18.000Z - 4 months ago

Mobia Medical indicated to open at $15, IPO priced at $15

2026-05-08T19:35:56.000Z - 4 months ago

Mobia Medical opens at $14, IPO priced at $15 per share

2026-05-08T03:45:10.000Z - 4 months ago

Mobia Medical 10M share IPO priced at $15.00

May 7, 2026, 10:10 PM EDT - 4 months ago

Mobia Medical Announces Pricing of Initial Public Offering

Apr 17, 2026, 11:01 AM EDT - 5 months ago

Mobia Medical IPO Registration Document (S-1)

Yingtrader7 Sep. 15 at 4:46 PM

$NSYS volume starting to inflate buy need more uptics. $MOBI moving also

0 · Reply

bigdaddysmang Sep. 11 at 7:47 PM

$MOBI some crazy movement today 🤷‍♂️

0 · Reply

Yingtrader7 Sep. 3 at 4:14 PM

$NSYS somebody please buy out this company. $MOBI

0 · Reply

Yingtrader7 Sep. 2 at 2:45 PM

$NSYS guess who's moving? $MOBI

0 · Reply

OkieDokieTrader Sep. 1 at 6:45 PM

$MOBI $CAST $FRVO $SUJA All IPO's from earlier this year. Starting to run!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

1 · Reply

Yingtrader7 Sep. 1 at 4:46 PM

$MOBI the Alligator Awakens,

0 · Reply

Yingtrader7 Sep. 1 at 4:05 PM

$NSYS top movers $SDGR , $APP , $WING , $MOBI for me.

0 · Reply

Yingtrader7 Sep. 1 at 3:58 PM

$NSYS did you guys forget about $MOBI i hope not

0 · Reply

Yingtrader7 Sep. 1 at 3:57 PM

$MOBI yes yes yes

0 · Reply

Yingtrader7 Aug. 30 at 12:15 PM

$NSYS I think Im going to track $MOBI for next week

0 · Reply

BigPlaySnipers Aug. 27 at 6:00 AM

I found 5 stocks today that are showing unusual activity. Here’s what I’m watching I built http://TheScanner.ai so I could find this stuff without jumping between 5 different platforms $CAPR $ANF $PLAB $MOBI $KLXE

1 · Reply

Form4Alerts Aug. 22 at 10:18 PM

Jun 25–Jul 22: 28 companies had 2+ insiders buying $250K+. Each held 30 days. All of them: · 19 up, 9 down (68%) · median +5.1% · SPY +4.4% · average +0.2% — the misses were bigger than the hits · best $GLOO +23.4% · worst $MOBI -28.2% Not a stock pick list — the full cohort, winners and losers. Not investment advice.

0 · Reply

AlertsAndNews Aug. 21 at 2:42 AM

$MOBI Insider action here as well. Director buy. Mobia Medical: Casey M. Tansey (Director) Buys 16,441 Shares @ Average Price of $12.07 (Form 4)

0 · Reply

AlertsAndNews Aug. 18 at 2:46 AM

$MOBI got some insider action here. From a director. Mobia Medical: Casey M. Tansey (Director) Buys 68,559 Shares @ Average Price of $11.63 (Form 4)

0 · Reply

FilingTracker Aug. 18 at 1:54 AM

$MOBI Insider purchase: https://filingtracker.ai/filing/1474322/0001193125-26-354538?doc=ownership.xml

0 · Reply

EarningsInsider Aug. 12 at 12:02 AM

https://www.marketbeat.com/earnings/reports/2026-8-11-mobia-medical-inc-stock/ $MOBI Mobia Medical Earnings Transcript

0 · Reply

StocktwitsEarnings Aug. 11 at 8:48 PM

$MOBI Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$1.10 up 91.16% YoY • Reported revenue of $13.51M up 102.35% YoY

0 · Reply

_ProfessorGamma Aug. 8 at 2:26 PM

$MOBI Kind of growing into it.

0 · Reply

bigdaddysmang Jul. 23 at 2:04 PM

$MOBI any particular reason this is acting like a pos?

0 · Reply

BioTuesdays Jul. 15 at 10:11 PM

$MOBI has announced the publication of two-year follow-up data from the VNS-REHAB study in Neurology, the peer-reviewed journal of the American Academy of Neurology, demonstrating that statistically significant and clinically meaningful improvements in upper-limb motor impairment and function, abilities of daily living, and quality of life were sustained for at least two years following completion of in-clinic Vivistim Paired VNS Therapy. https://biotuesdays.com/2026/07/15/neurology-publishes-mobias-two-year-vns-rehab-data-demonstrating-sustained-stroke-recovery/

0 · Reply

bigdaddysmang Jul. 14 at 7:21 PM

$MOBI big buy!

0 · Reply

amda Jul. 14 at 5:09 PM

$MOBI success! ST responded to my email and has corrected this page. Thanks ST!

0 · Reply

Market Cap	333.91M
Revenue (ttm)	32.04M
Net Income (ttm)	-46.50M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-145.13%
Debt to Equity Ratio	0.04

Volume	316,900
Avg Vol	132,194
Day's Range	N/A - N/A
Shares Out	33.29M
Stochastic %K	37%
Beta	N/A
Analysts	Strong Sell
Price Target	$20.40